Video Interview: Navigating the Biopharma Landscape – The Strategic Shift to Biologics

At Rentschler Biopharma, we have recently shifted to biologics CDMO services. In this interview with BioPharm International, our CEO, Benedikt von Braunmühl, highlights how this new strategic direction will enhance our capabilities in both the US and Europe, allowing us to help our clients navigate the current market landscape more effectively.

Watch this video to learn more about:

• Why Rentschler Biopharma is undergoing this strategic shift.
• Where the biopharma market is heading, especially in the US and Europe.
• How the company's new strategic orientation supports clients globally to navigate the current (geopolitical) market situation.